# Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

> **NCT00478985** · NA · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 100 (actual)

## Conditions studied

- Myeloid Leukemia, Chronic

## Interventions

- **BEHAVIORAL:** Imatinib ending

## Key facts

- **NCT ID:** NCT00478985
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478985, "Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00478985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*